Viewpoint: How can scientists update coronavirus vaccines for omicron?
A microbiologist answers five questions about how Moderna and Pfizer could rapidly adjust mRNA vaccines
Conclusions: The novel SARS-CoV-2 vaccine upregulates the immune system to produce an adaptive immune response. The SARS-CoV-2 vaccine may potentially be associated with increased risk of rejection in those with ocular surface transplants.
Conclusions: To the best of our knowledge, this case of full-thickness graft rejection after the Moderna SARS-CoV-2 mRNA vaccination is the first to be reported worldwide. The temporal relationship between vaccination and subsequent rejection is highly suggestive of causation due to the short interval (3 days) between vaccination and rejection and the lack of other inciting factors in an otherwise healthy graft. Patients with corneal transplants who plan to take the COVID-19 vaccinations should be counseled on symptoms and closely monitored, and an individualized plan should be made in discussion with the ophthalmologist.
This report describes a case of aseptic meningitis 3 weeks after administration of the second dose of Comirnaty. The patient recovered with conservative and symptomatic care after 5 days of admission. Surveillance of rare adverse events, including aseptic meningitis, and their management should be prompt and appropriate.
It is too soon to know, scientists say, but mild initial illness may not signal reduced risk.
InnovationRx is your weekly digest of healthcare news. Sign up!
A new study that compares coronavirus protection from prior infection and vaccination concludes getting the shots is still the safest way to prevent COVID-19
Plan B measures such as mask wearing and vaccine passports for large venues will not be renewed after January 26
Public health law expert Lawrence Gostin explains how the Supreme Court ’s ruling against OSHA’s ability to implement a vaccine-or-test mandate could potentially undermine the federal government’s ability to effectively respond to public health emergencies.
This report describes COVID-19 cases and hospitalizations by vaccination status and previous COVID-19 diagnosis before and after the Delta variant became predominant.
As with any other ineradicable disease, prevention and treatment can be integrated into societyDelaying and preventing infection as much as possible through this pandemic was a worthwhile strategy. In early 2020, there were few treatments, limited testing and no vaccines. The costs of those lockdowns were big, but the effort to buy time paid off. In that time, science has transformed Covid from a deadly virus to a much less serious, nasty disease – one that is manageable at home, for the vast majority of those vaccinated. It has, largely, defanged it.But even as we have had success treating and preventing serious inf...